SPARTANBURG — Gibbs Cancer Center & Research Institute is the first in the United States to treat cancer patients using the CyberKnife® M6™ with the next-generation InCise™ Multileaf Collimation System.
The CyberKnife is a noninvasive radiation treatment device which uses advanced imaging and robotics to accurately treat tumors.
InCise uses tiny radiation-blocking “fingers”, or ”leaves” which reduce the dose to surrounding healthy tissue while maintaining an effective dose to the target tissue. Using this technology, treatment times are cut in half, dose to patients’ vital organs is reduced, and the CyberKnife is capable of treater larger lesions.
“This community now has something else in which to pride ourselves,” said David Church, Ph.D., Vice President of Oncology and Support Services for Gibbs. “The InCise system is a great example of how our physicians and staff are leading the nation in the advancement of cancer care.”
In additional to treating brain and lung lesions, Gibbs Cancer Center currently uses the CyberKnife to provide low- and medium-risk prostate cancer patients with a fast, non-invasive, and accurate treatment option; delivering a complete treatment in 5 treatments instead of the traditional 44 treatments.
“Our prostate cancer patients stand to gain the most from the InCise collimator,” said Gibbs radiation oncologist and medical director, Daniel Fried, MD, PhD. “We’ve substantially reduced treatment times, greatly enhancing their comfort during this non-invasive procedure.”
“We are applying this new technology to continually improve treatments for our cancer patients, including patients with lung lesions and multiple brain metastases,” Fried said.
“This is an example of the continual progress that Gibbs Cancer Center & Research Institute makes in treating cancer,” said Gibbs physicist, Jacob Gersh, PhD. “We are raising the bar once again; providing our patients with faster and clinically superior treatment.”
Call 1-855-DNA-GIBBS to find out if you are candidate for CyberKnife treatment.
About Gibbs Cancer Center & Research Institute
Gibbs Cancer Center & Research Institute is a nationally recognized cancer treatment and research facility associated with the National Cancer Institute Community Cancer Center program and the Medical University of South Carolina. Named for benefactors Marsha and Jimmy Gibbs and with locations in Spartanburg, Gaffney and Greer, Gibbs is a proven leader in providing effective cancer treatment through advanced technology, professional expertise and an exceptional level of personalized care. Gibbs’ oncology program, which also includes the Bearden-Josey Center for Breast Health, has been recognized by the Commission on Cancer of the American College of Surgeons as offering high-quality cancer care. In 2012, Gibbs joined forces with Bon Secours St. Francis Health System to expand world-class oncology services and clinical research in the Upstate. In 2013, the Gibbs expanded its research efforts by opening a 7,500-square-foot state-of-the-art facility at Pelham Medical Center.
About Spartanburg Regional Healthcare System
Spartanburg Regional Healthcare System (SRHS) offers a full spectrum of services through four hospitals: Spartanburg Medical Center, Pelham Medical Center, Spartanburg Hospital for Restorative Care and Union Medical Center. SRHS also includes Ellen Sagar Nursing Center, 113-bed long-term care, skilled nursing facility that offers nursing care and rehabilitation services. SRHS provides unparalleled oncological care through the Gibbs Cancer Center & Research Institute. The multidisciplinary Medical Group of the Carolinas has more than 300 physicians across seven counties in two states. SRHS employs nearly 6,000 associates and offers outpatient surgery centers, a vibrant post-acute division, a Level I Trauma Center, and Advicare, a licensed Health Maintenance Organization (HMO). Advicare provides Medicaid services to residents throughout the state of South Carolina. U.S. News and World Report ranked Spartanburg Medical Center the No. 1 regional hospital in South Carolina in 2014-15. The Commission on Cancer gave Gibbs Cancer Center & Research Institute its Outstanding Achievement Award.